tiprankstipranks
Advertisement
Advertisement
Amneal Pharmaceuticals announces FDA approval of romidepsin injection solution
PremiumThe FlyAmneal Pharmaceuticals announces FDA approval of romidepsin injection solution
1M ago
Amneal Pharmaceuticals price target raised to $16 from $15 at Barclays
Premium
The Fly
Amneal Pharmaceuticals price target raised to $16 from $15 at Barclays
2M ago
Amneal Pharma Bets Big on Biosimilars in Q1 Call
Premium
Company Announcements
Amneal Pharma Bets Big on Biosimilars in Q1 Call
2M ago
Is AMRX a Buy, Before Earnings?
PremiumPre-EarningsIs AMRX a Buy, Before Earnings?
2M ago
Amneal to Acquire Kashiv, Expanding Biosimilars Platform
Premium
Company Announcements
Amneal to Acquire Kashiv, Expanding Biosimilars Platform
2M ago
Amneal Pharmaceuticals raises FY26 adjusted EPS view to 95c-$1.05 from 93c-$1.03
Premium
The Fly
Amneal Pharmaceuticals raises FY26 adjusted EPS view to 95c-$1.05 from 93c-$1.03
2M ago
Amneal announces U.S. launch of two respiratory metered-dose inhalation products
PremiumThe FlyAmneal announces U.S. launch of two respiratory metered-dose inhalation products
3M ago
Amneal Pharmaceuticals Earnings Call: Growth Amid Transition
Premium
Company Announcements
Amneal Pharmaceuticals Earnings Call: Growth Amid Transition
4M ago
Amneal Pharmaceuticals price target raised to $17 from $15 at Goldman Sachs
Premium
The Fly
Amneal Pharmaceuticals price target raised to $17 from $15 at Goldman Sachs
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100